Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Trip 

Minerva Neurosciences Inc. diskutieren

Minerva Neurosciences Inc.

WKN: A3DMH5 / Symbol: NERV / Name: Minerva Neurosciences / Aktie / Biotechnologie & medizinische Forschung / Small Cap /

2,48 €
5,00 %

Sell Minerva Neurosciences Inc.

Minerva Neurosciences, Inc. (NASDAQ: NERV) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for NERV provided by MarketBeat

Minerva Neurosciences, Inc. (NASDAQ: NERV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for NERV provided by MarketBeat

Minerva Neurosciences, Inc. (NASDAQ: NERV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for NERV provided by MarketBeat

Minerva Neurosciences, Inc. (NASDAQ: NERV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for NERV provided by MarketBeat

Minerva Neurosciences, Inc. (NASDAQ: NERV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for NERV provided by MarketBeat

Minerva Neurosciences, Inc. (NASDAQ: NERV) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for NERV provided by MarketBeat

Minerva Neurosciences, Inc. (NASDAQ: NERV) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for NERV provided by MarketBeat

Minerva Neurosciences, Inc. (NASDAQ: NERV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for NERV provided by MarketBeat

Minerva Neurosciences, Inc. (NASDAQ: NERV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for NERV provided by MarketBeat

Minerva Neurosciences, Inc. (NASDAQ: NERV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for NERV provided by MarketBeat

Minerva Neurosciences, Inc. (NASDAQ: NERV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for NERV provided by MarketBeat

Minerva Neurosciences, Inc. (NASDAQ: NERV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for NERV provided by MarketBeat

Minerva Neurosciences, Inc. (NASDAQ: NERV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for NERV provided by MarketBeat

Minerva Neurosciences, Inc. (NASDAQ: NERV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for NERV provided by MarketBeat